000 | 04171nam a22006135i 4500 | ||
---|---|---|---|
001 | 978-3-031-35811-1 | ||
003 | DE-He213 | ||
005 | 20240207153744.0 | ||
007 | cr nn 008mamaa | ||
008 | 231110s2023 sz | s |||| 0|eng d | ||
020 |
_a9783031358111 _9978-3-031-35811-1 |
||
050 | 4 | _aRS199.5 | |
072 | 7 |
_aTCB _2bicssc |
|
072 | 7 |
_aSCI010000 _2bisacsh |
|
072 | 7 |
_aTCB _2thema |
|
082 | 0 | 4 |
_a615.6 _223 |
245 | 1 | 0 |
_aPharmaceutical Formulations for Older Patients _h[electronic resource] / _cedited by Mine Orlu, Fang Liu. |
250 | _a1st ed. 2023. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2023. |
|
300 |
_aXIII, 288 p. 63 illus., 61 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aAAPS Advances in the Pharmaceutical Sciences Series, _x2210-738X ; _v51 |
|
500 | _aAcceso multiusuario | ||
505 | 0 | _aPart 1: Patient-Centric Considerations.-Medicine Optimisation in Older -- Acceptability of drug formulations in older patients and effect on patient adherence -- Geriatric biopharmaceutics -- Excipient safety in older adults -- Part 2: Pharmaceutical Formulations Development for older Patients -- Oral and oromucosal formulation development and in vitro characterisation - patient-centric approaches for older adults -- Pulmonary drug delivery systems for older people -- Transdermal drug delivery systems for older patients -- Part 3 :Advanced Drug Delivery Systems for Older Patients -- Advanced oral drug delivery systems for older patients -- The ageing microbiome, pharmaceutical considerations and therapeutic opportunities -- Application of 3D printing in geriatric medicines, -- Application of electrospraying and advanced fabrication methods in geriatric medicines -- Vaccine development for older patients. | |
520 | _aPharmaceutical formulation design affects patient acceptability/adherence and pharmacokinetics of the drug. This is particularly important for older patients because of the physiological changes due to ageing and clinical/social circumstances related to medicine taking. This book provides a comprehensive review in the design of formulations to meet the needs of older patients. An overview of the key clinical, social and pharmaceutical factors affecting medication optimization, safety and acceptability in older adults is included, followed by patient-centric considerations including regulatory requirements, dosage form design and human factor studies. Advanced pharmaceutical technologies are discussed for their potential use in older adults such as 3D printing, long-acting oral formulations and novel vaccine technologies. The unique focus of the book will be of interest to pharmaceutical scientists in both industry and academia in searching for better formulations for older patients. | ||
541 |
_fUABC ; _cPerpetuidad |
||
650 | 0 | _aDrug delivery systems. | |
650 | 0 | _aPharmaceutical chemistry. | |
650 | 0 | _aPharmacology. | |
650 | 0 |
_aMedicine _xResearch. |
|
650 | 0 |
_aBiology _xResearch. |
|
650 | 1 | 4 | _aDrug Delivery. |
650 | 2 | 4 | _aPharmaceutics. |
650 | 2 | 4 | _aPharmacology. |
650 | 2 | 4 | _aBiomedical Research. |
700 | 1 |
_aOrlu, Mine. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aLiu, Fang. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783031358104 |
776 | 0 | 8 |
_iPrinted edition: _z9783031358128 |
776 | 0 | 8 |
_iPrinted edition: _z9783031358135 |
830 | 0 |
_aAAPS Advances in the Pharmaceutical Sciences Series, _x2210-738X ; _v51 |
|
856 | 4 | 0 |
_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-35811-1 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c263225 _d263224 |